pharmaphorum

JANUARY 29, 2023

Anti-P-selectin antibody Adakveo became the first new treatment for VOCs in SCD patients in decades when it was approved for marketing in the EU, a few months after the FDA gave it the nod in the US, on the strength of the SUSTAIN trial results. That study showed that Adakveo lowered the median annual rate of VOCs to 1.63 compared to 2.98

Genotype 52

Genotype Trials Antibody Regulation 52

pharmaphorum

AUGUST 11, 2022

The program is aiming to genotype roughly 150,000 participants over the next few years to demonstrate the impact personalised testing can have on a large scale. In the near future, more testing must be put into place and standardised throughout the industry. The post How Pharmacogenomics may finally realise its promise appeared first on.

Genome 98

Genome Genomics Drugs Genetics 98

pharmaphorum

JANUARY 24, 2023

Rather than be provided a therapy that has been tested across a broad range of the population, there are now many therapies on the market that are designed specifically to work for sub-populations within disease areas. Recent years have brought a revolution to the way in which patients receive treatment.

Genetics 98

Genetics Drugs Genome Project Biobanking 98

The Pharma Data

SEPTEMBER 8, 2021

TIB Molbiol is a biotech company that has supplied the global market with reagents for research and medical diagnostics for over 30 years. To support customers performing human genotyping, TIB Molbiol provides custom made LightSNiP assays for SNP analysis. About TIB Molbiol.

Genotype 52

Genotype Reagent Genetics Research 52

Roots Analysis

AUGUST 12, 2024

It is worth mentioning that molecular diagnostics is a subset of the broader in vitro diagnostics market. According to the World Health Organization, there are over 40,000 in vitro diagnostics products available in the market. Such test can be used for gene expression profiling, genotyping and detecting chromosomal abnormalities.

Genetics 40

Genetics Gene Expression RNA DNA 40

Roots Analysis

SEPTEMBER 20, 2023

The market for cannabis-infused products is growing like weed. The legalization of the plant for medical and recreational applications has led to profound growth of this market across the globe. Cannabis testing is also done to identify the plant genotype used to develop the product, providing transparency to the consumers.

Laboratory Information Management System 40

Laboratory Information Management System Production Contamination Containment 40

XTalks

DECEMBER 12, 2023

The worldwide market for neurology clinical trials stood at a valuation of $5.24 To accurately identify these genetic factors, genotyping techniques such as Sanger sequencing, next-generation sequencing (NGS) and copy number variant analysis are used. billion in 2022. It’s projected to grow at a compound annual growth rate (CAGR) of 5.6

Trials 111

Trials Clinical Trials Clinical Trials Genetics 111

Roots Analysis

AUGUST 31, 2023

Current Approaches / Processes for Offering Genomic Tests Presently, owing to the significant reduction in the cost of genotyping and sequencing, there has been a significant rise in the number of nutrigenomics companies offering genetic testing services directly to the consumers without the involvement of clinicians.

Genome 40

Genome Genomics Genetics Gene 40

Delveinsight

DECEMBER 13, 2020

Hepatitis C treatment options, without a doubt, have improved significantly, including pan-genotypic medications that are used to treat all genotypes and subtypes. Typically, pan-genotypic treatments have high cure rates, few side effects, and short treatment durations (usually 8–12 weeks). and GT2 and GT3 with ribavirin.

Genotype 52

Genotype FDA Approval DNA Drugs 52

XTalks

JULY 10, 2024

The US Food and Drug Administration (FDA) has granted marketing authorization to Cepheid for its groundbreaking Xpert HCV test and GeneXpert Xpress System, marking a significant advancement in the diagnosis and treatment of hepatitis C virus (HCV). North America dominated the market in 2018 with a 47.46 percent share.

RNA 97

RNA In-Vitro Genotype Marketing 97

The Pharma Data

NOVEMBER 2, 2020

ONWARD is investigating Adial’s lead drug candidate, AD04, as a therapeutic agent for the treatment of Alcohol Use Disorder (AUD) in persons with certain target genotypes related to the serotonin transporter and receptor genes. The European market is expected to be similar in size. ” About Adial Pharmaceuticals, Inc.

Trials 52

Trials Genotype Marketing Production 52

The Pharma Data

MARCH 7, 2022

Food and Drug Administration announced it has made a low-risk determination for the marketing of products, including food, from two genome-edited beef cattle and their offspring after determining that the intentional genomic alteration (IGA) does not raise any safety concerns (low-risk determination).

Genome 52

Genome Genomics Production Marketing 52

The Pharma Data

DECEMBER 9, 2020

Vigil’s pipeline strategy is to target these diseases by combining a high-level understanding of microglia physiology, disease genotyping, and patient phenotyping to identify specific genetic variations associated with microglial dysfunction.

Marketing 52

Marketing In-Vivo Protein In-Vitro 52

pharmaphorum

NOVEMBER 10, 2021

This database should support automatic importation from hospitals, laboratories and surveillance networks and link to genotypic data when available.”. The medicines needed to treat resistant infections are complicated to develop and have a relatively small market both in terms of duration of use, usually only a few days, and need,” it said.

Medicine 105

Medicine Genome Genomics Genotype 105

XTalks

JANUARY 22, 2021

It identifies bacteria using both genotypic and phenotypic assessments within 1.5 He goes on to say, “No medical device currently in the market is able to conduct an antibiotics combination test to either confirm or predict if a combination is effective. fAST: Automated Bacteria Identification and Multiple Antibiotics Combination Test.

Bacteria 52

Bacteria In-Vitro Genotype Marketing 52

XTalks

APRIL 24, 2023

This is an increase from the EMA’s approval of two novel ATMPs with orphan designation in 2021 (although the marketing authorization for one of these ATMPs was withdrawn in the European Union in November 2021) and three novel ATMPs with orphan designation in 2020. How Can Study Protocols Be More Effective? “A

Gene Therapy 95

Gene Therapy Gene Trials Clinical Trials 95

The Pharma Data

APRIL 7, 2021

The European Medicines Agency has also validated a Marketing Authorization Application for Trodelvy in the European Union. The incidence of Grade 3-4 neutropenia in genotyped patients was 69% in patients homozygous for the UGT1A1*28, 48% in patients heterozygous for the UGT1A1*28 allele and 46% in patients homozygous for the wild-type allele.

HR 52

HR Genotype FDA Approval Genotoxicity 52

The Pharma Data

MARCH 25, 2021

The validation of our EU marketing application is an important step toward addressing the significant unmet medical need for people with metastatic triple-negative breast cancer.”. including final safety information for prescribers) will be assessed as part of ongoing and future Marketing Authorization Applications.

Genotoxicity 52

Genotoxicity Genotype Containment Protein 52

The Pharma Data

NOVEMBER 24, 2020

On November 19, the European Commission granted marketing authorization for Oxlumo for the treatment of PH1 in all age groups, following a positive opinion from the Committee for Medicinal Products for Human Use (CHMP).

FDA Approval 52

FDA Approval Production RNA Medicine 52

The Pharma Data

MARCH 16, 2022

3, and Delta ([link] About TIB Molbiol TIB Molbiol is a subsidiary of Roche Diagnostics that has supplied the global market with reagents for research and medical diagnostics for over 30 years. To support customers performing human genotyping, TIB Molbiol provides custom-made LightSNiP assays for SNP analysis.

In-Vitro 52

In-Vitro Genotype Reagent Protein 52

Delveinsight

AUGUST 25, 2021

They are governed by a number of rules and regulations that govern drug patenting, testing, safety, efficacy, and marketing. . Johnson and Johnson are evaluating a variety of drugs for several indications that may soon join the respective market in the upcoming years. The global healthcare spending in 2020 was USD 8.3 trillion in 2021.

Vaccine 98

Vaccine Vaccination Drugs Sales 98

XTalks

NOVEMBER 9, 2023

While there are commonly used HPV tests in the market, not all are approved for primary screening and only provide limited information about the different genotypes of HPV present. Molecular testing for HPV types that are known to cause cervical cancer is certainly welcome as Pap tests are invasive and can be uncomfortable.

FDA Approval 64

FDA Approval HR Genotype Life Science 64

Delveinsight

DECEMBER 16, 2020

As per the WHO, more than 100 types of HPV are found worldwide, out of them at least 13 known HPV genotypes can cause cancer of the cervix. A number of antiretroviral drugs are available in the market today, that can be combined in different ways. Presently many pipeline therapies are under development for the Genital Herpes.

Bacteria 52

Bacteria Development Genotype Vaccine 52

XTalks

MARCH 26, 2025

Attendees will learn how clinical trial assays and genotyping kits can enhance research and clinical insight. Total cash, cash equivalents and marketable securities amounted to approximately $132.2 Zetomipzomib is a first-in-class selective immunoproteasome inhibitor. This was down from $201.4 million as of December 31, 2023.

Trials 66

Trials Life Science Clinical Trials Clinical Trials 66